Stock Information
Madrigal Pharmaceuticals Inc (MDGL)
Ticker Symbol: MDGL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $12,420.65 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -12.8503
Revenue (TTM): $41.76 M
Dividend Yield: N/A%
ROE: -43.76%
Latest News
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Thu, May 7, 2026 4:07 PM
-
Evercore ISI Group Maintains Outperform on Madrigal Pharmaceuticals, Lowers Price Target to $649
Thu, May 7, 2026 10:44 AM
-
Earnings Scheduled For May 6, 2026
Wed, May 6, 2026 5:03 PM
-
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2026 Earnings Call Transcript
Wed, May 6, 2026 2:01 PM
-
Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Dip Despite Q1 2026 Earnings Beat and 127% Rezdiffra Revenue Growth
Wed, May 6, 2026 12:29 PM
-
Madrigal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Wed, May 6, 2026 10:41 AM
-
Transcript : Madrigal Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 06, 2026
Wed, May 6, 2026 9:35 AM
-
Full Transcript: Madrigal Pharmaceuticals Q1 2026 Earnings Call
Wed, May 6, 2026 9:23 AM
-
Madrigal Pharmaceuticals : MDGL 1Q26 Earnings Presentation
Wed, May 6, 2026 8:12 AM
-
HC Wainwright & Co. Reiterates Buy on Madrigal Pharmaceuticals, Maintains $620 Price Target
Wed, May 6, 2026 8:02 AM
Key Financials
Financial data not available
